- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01994616
Prospective Evaluation of the Use of Intralesional Cryotherapy for Treatment of Keloid and Hypertrophic Scars
November 19, 2013 updated by: Michiel van Leeuwen, Amsterdam UMC, location VUmc
Intralesional Cryotherapy for Treatment of Keloid Scars: a Prospective Evaluation
This prospective evaluation studies the effectiveness of IL cryotherapy in treating keloids and hypertrophic scars in a large population of mixed Fitzpatrick skin types.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Intralesional (IL) cryotherapy is a novel treatment for keloids and hypertrophic scars, in which the scar is frozen from inside.
Published results are promising, however only Caucasian patient populations have been studied.
This prospective evaluation studies the effectiveness of IL cryotherapy in treating keloids and hypertrophic scars in a large population of mixed Fitzpatrick skin types.
All patients with keloid or hypertrophic scars meeting inclusion criteria were treated with a liquid nitrogen based device called Cryoshape Scar quality and possible recurrence are assessed pre- and postsurgery (3, 6 and 12 months) with objective devices determine scar color, scar elasticity, scar volume and patient's skin type.
In addition, scars are evaluated using the Patient and Observer Scar Assessment Scale.
Study Type
Observational
Enrollment (Actual)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Noord-Holland
-
Amsterdam, Noord-Holland, Netherlands, 1081HV
- VUMC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
A mixed patient population with all Fitzpatrick skin types
Description
Inclusion Criteria:
- Keloids, defined as excessive scar tissue raised above skin level and proliferating beyond the confines of the original lesion
- Hypertrophic scars1 older than 12 months and insensitive to other treatments. Keloids were distinguished from hypertrophic scars based on the clinical judgment of experienced plastic surgeons and on the age of the scar (>1yr)
- A period between previous treatment and IL cryotherapy covered a minimum of 12 weeks
- Patients with all Fitzpatrick17 skin types
- Patients older than 10 years of age
Exclusion Criteria:
- pregnancy
- diabetes mellitus
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
keloid or hypertrophic scars
All patient including all skin types with keloid or hypertrophic disease receiving Intralesional Cryotherapy
|
Intralesional (IL) cryotherapy is a treatment for keloids and hypertrophic scars, in which the scar is frozen from inside with the use of a cryoneedle
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recurrence
Time Frame: 0-12 months
|
Judgment of recurrence, defined as a growing, pruritic, nodular scar
|
0-12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Scar elasticity
Time Frame: 0-12months
|
Scar elasticity, measured in two parameters: extension and elasticity
|
0-12months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Scar volume
Time Frame: 0-12months
|
Determined by creating a mold of the scar with dental putty
|
0-12months
|
Redness (erythema) and pigmentation (melanin),
Time Frame: 0-12months
|
Redness (erythema) and pigmentation (melanin), which were measured using the DermaSpectrometer
|
0-12months
|
Subjective scar evaluation
Time Frame: 0-12months
|
performed by two experienced medical doctors and the patient using the Patient and Observer Scar Assessment Scale (POSAS).
Each item of the POSAS was scored using a 10-step score, in which 10 reflected 'worst scar imaginable' and 1 indicated 'normal skin'
|
0-12months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Michiel CE van Leeuwen, MD, VUMC
- Study Director: Frank B Niessen, PhD, MD, VUMC
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Har-Shai Y, Amar M, Sabo E. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconstr Surg. 2003 May;111(6):1841-52. doi: 10.1097/01.PRS.0000056868.42679.05.
- van Leeuwen MCE, van der Wal MBA, Bulstra AJ, Galindo-Garre F, Molier J, van Zuijlen PPM, van Leeuwen PAM, Niessen FB. Intralesional cryotherapy for treatment of keloid scars: a prospective study. Plast Reconstr Surg. 2015 Feb;135(2):580-589. doi: 10.1097/PRS.0000000000000911.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2009
Primary Completion (Actual)
January 1, 2011
Study Completion (Actual)
June 1, 2011
Study Registration Dates
First Submitted
November 19, 2013
First Submitted That Met QC Criteria
November 19, 2013
First Posted (Estimate)
November 26, 2013
Study Record Updates
Last Update Posted (Estimate)
November 26, 2013
Last Update Submitted That Met QC Criteria
November 19, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12/292
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cicatrix, Hypertrophic
-
Samsung Medical CenterSeoul National University Hospital; Kyunghee University Medical Center; InovailUnknownHypertrophic CicatrixKorea, Republic of
-
Massachusetts General HospitalWithdrawnHypertrophic ScarsUnited States
-
Mahidol UniversityCompleted
-
Association of Dutch Burn CentresBausch Health Americas, Inc.Unknown
-
Cairo UniversityUnknown
-
Fidia Farmaceutici s.p.a.Recruiting
-
SirnaomicsCompletedHypertrophic ScarUnited States
-
SirnaomicsNot yet recruiting
-
Cairo UniversityCompleted
Clinical Trials on Intralesional cryotherapy
-
Amsterdam UMC, location VUmcCompletedCicatrix | Keloid | HypertrophicNetherlands
-
Cairo UniversityRecruiting
-
Carmel Medical CenterUnknownBasal Cell Carcinoma (BCC)Israel
-
Combined Military Hospital AbbottabadCompleted
-
Chaitanya Hospital, PuneUnknownMuscular Dystrophy | Duchenne Muscular DystrophyIndia
-
Istituto Ortopedico RizzoliCompletedChondrosarcoma | Chondroma
-
Combined Military Hospital AbbottabadCompletedCutaneous WartsPakistan
-
Pulse Biosciences, Inc.CompletedSkin Abnormalities | Skin Lesion | Sebaceous HyperplasiaUnited States
-
Cairo UniversityNot yet recruiting
-
Creighton UniversityCompleted